Absolute Bioavailability Study With Bexagliflozin

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 1, 2018

Primary Completion Date

September 16, 2018

Study Completion Date

September 16, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Bexagliflozin

Bexagliflozin tablets, 20 mg, and bexagliflozin by IV

Trial Locations (1)

53704

Clinical Research Site, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theracos

INDUSTRY